MedPath
FDA Approval

Sildenafil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 24, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Sildenafil(20 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Northwind Pharmaceuticals, LLC

036986393

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Northwind Pharmaceuticals, LLC

Northwind Pharmaceuticals, LLC

Northwind Pharmaceuticals, LLC

036986393

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sildenafil

Product Details

NDC Product Code
51655-172
Application Number
ANDA202025
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 24, 2023
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
CALCIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Code: 701EKV9RMNClass: IACT
Code: BW9B0ZE037Class: ACTIMQuantity: 20 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath